Acetaminophen attenuates lipopolysaccharide-induced cognitive impairment through antioxidant activity

Background Considerable evidence has shown that neuroinflammation and oxidative stress play an important role in the pathophysiology of postoperative cognitive dysfunction (POCD) and other progressive neurodegenerative disorders. Increasing evidence suggests that acetaminophen (APAP) has unappreciat...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of neuroinflammation Vol. 14; no. 1; p. 17
Main Authors:	Zhao, Wei-Xing, Zhang, Jun-Han, Cao, Jiang-Bei, Wang, Wei, Wang, Dong-Xin, Zhang, Xiao-Ying, Yu, Jun, Zhang, Yong-Yi, Zhang, You-Zhi, Mi, Wei-Dong
Format:	Journal Article
Language:	English
Published:	London BioMed Central 21.01.2017 BioMed Central Ltd Springer Nature B.V
Subjects:	Acetaminophen Acetaminophen - pharmacology Animals Antioxidants Antioxidants - pharmacology Biomedical and Life Sciences Biomedicine Cognition disorders Cognitive Dysfunction - chemically induced Dosage and administration Drug therapy Hippocampus - drug effects Immunology Lipopolysaccharides Lipopolysaccharides - toxicity Male Maze Learning - drug effects Mice Mice, Inbred C57BL Motor Activity - drug effects Neurobiology Neurology Neuroprotective Agents - pharmacology Neurosciences Oxidative stress Memory impairment Acetaminophen Antioxidant activity Neuroinflammation Neuroprotective therapy Apoptosis
ISSN:	1742-2094, 1742-2094
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Abstract	Background Considerable evidence has shown that neuroinflammation and oxidative stress play an important role in the pathophysiology of postoperative cognitive dysfunction (POCD) and other progressive neurodegenerative disorders. Increasing evidence suggests that acetaminophen (APAP) has unappreciated antioxidant and anti-inflammatory properties. However, the impact of APAP on the cognitive sequelae of inflammatory and oxidative stress is unknown. The objective of this study is to explore whether APAP could have neuroprotective effects on lipopolysaccharide (LPS)-induced cognitive impairment in mice. Methods A mouse model of LPS-induced cognitive impairment was established to evaluate the neuroprotective effects of APAP against LPS-induced cognitive impairment. Adult C57BL/6 mice were treated with APAP half an hour prior to intracerebroventricular microinjection of LPS and every day thereafter, until the end of the study period. The Morris water maze was used to assess cognitive function from postinjection days 1 to 3. Animal behavioural tests as well as pathological and biochemical assays were performed to evaluate LPS-induced hippocampal damage and the neuroprotective effect of APAP. Results Mice treated with LPS exhibited impaired performance in the Morris water maze without changing spontaneous locomotor activity, which was ameliorated by treatment with APAP. APAP suppressed the accumulation of pro-inflammatory cytokines and microglial activation induced by LPS in the hippocampus. In addition, APAP increased SOD activity, reduced MDA levels, modulated glycogen synthase kinase 3β (GSK3β) activity and elevated brain-derived neurotrophic factor (BDNF) expression in the hippocampus. Moreover, APAP significantly decreased the Bax/Bcl-2 ratio and neuron apoptosis in the hippocampus of LPS-treated mice. Conclusions Our results suggest that APAP may possess a neuroprotective effect against LPS-induced cognitive impairment and inflammatory and oxidative stress via mechanisms involving its antioxidant and anti-inflammatory properties, as well as its ability to inhibit the mitochondrial permeability transition (MPT) pore and the subsequent apoptotic pathway.
AbstractList	Background Considerable evidence has shown that neuroinflammation and oxidative stress play an important role in the pathophysiology of postoperative cognitive dysfunction (POCD) and other progressive neurodegenerative disorders. Increasing evidence suggests that acetaminophen (APAP) has unappreciated antioxidant and anti-inflammatory properties. However, the impact of APAP on the cognitive sequelae of inflammatory and oxidative stress is unknown. The objective of this study is to explore whether APAP could have neuroprotective effects on lipopolysaccharide (LPS)-induced cognitive impairment in mice. Methods A mouse model of LPS-induced cognitive impairment was established to evaluate the neuroprotective effects of APAP against LPS-induced cognitive impairment. Adult C57BL/6 mice were treated with APAP half an hour prior to intracerebroventricular microinjection of LPS and every day thereafter, until the end of the study period. The Morris water maze was used to assess cognitive function from postinjection days 1 to 3. Animal behavioural tests as well as pathological and biochemical assays were performed to evaluate LPS-induced hippocampal damage and the neuroprotective effect of APAP. Results Mice treated with LPS exhibited impaired performance in the Morris water maze without changing spontaneous locomotor activity, which was ameliorated by treatment with APAP. APAP suppressed the accumulation of pro-inflammatory cytokines and microglial activation induced by LPS in the hippocampus. In addition, APAP increased SOD activity, reduced MDA levels, modulated glycogen synthase kinase 3β (GSK3β) activity and elevated brain-derived neurotrophic factor (BDNF) expression in the hippocampus. Moreover, APAP significantly decreased the Bax/Bcl-2 ratio and neuron apoptosis in the hippocampus of LPS-treated mice. Conclusions Our results suggest that APAP may possess a neuroprotective effect against LPS-induced cognitive impairment and inflammatory and oxidative stress via mechanisms involving its antioxidant and anti-inflammatory properties, as well as its ability to inhibit the mitochondrial permeability transition (MPT) pore and the subsequent apoptotic pathway. Considerable evidence has shown that neuroinflammation and oxidative stress play an important role in the pathophysiology of postoperative cognitive dysfunction (POCD) and other progressive neurodegenerative disorders. Increasing evidence suggests that acetaminophen (APAP) has unappreciated antioxidant and anti-inflammatory properties. However, the impact of APAP on the cognitive sequelae of inflammatory and oxidative stress is unknown. The objective of this study is to explore whether APAP could have neuroprotective effects on lipopolysaccharide (LPS)-induced cognitive impairment in mice.BACKGROUNDConsiderable evidence has shown that neuroinflammation and oxidative stress play an important role in the pathophysiology of postoperative cognitive dysfunction (POCD) and other progressive neurodegenerative disorders. Increasing evidence suggests that acetaminophen (APAP) has unappreciated antioxidant and anti-inflammatory properties. However, the impact of APAP on the cognitive sequelae of inflammatory and oxidative stress is unknown. The objective of this study is to explore whether APAP could have neuroprotective effects on lipopolysaccharide (LPS)-induced cognitive impairment in mice.A mouse model of LPS-induced cognitive impairment was established to evaluate the neuroprotective effects of APAP against LPS-induced cognitive impairment. Adult C57BL/6 mice were treated with APAP half an hour prior to intracerebroventricular microinjection of LPS and every day thereafter, until the end of the study period. The Morris water maze was used to assess cognitive function from postinjection days 1 to 3. Animal behavioural tests as well as pathological and biochemical assays were performed to evaluate LPS-induced hippocampal damage and the neuroprotective effect of APAP.METHODSA mouse model of LPS-induced cognitive impairment was established to evaluate the neuroprotective effects of APAP against LPS-induced cognitive impairment. Adult C57BL/6 mice were treated with APAP half an hour prior to intracerebroventricular microinjection of LPS and every day thereafter, until the end of the study period. The Morris water maze was used to assess cognitive function from postinjection days 1 to 3. Animal behavioural tests as well as pathological and biochemical assays were performed to evaluate LPS-induced hippocampal damage and the neuroprotective effect of APAP.Mice treated with LPS exhibited impaired performance in the Morris water maze without changing spontaneous locomotor activity, which was ameliorated by treatment with APAP. APAP suppressed the accumulation of pro-inflammatory cytokines and microglial activation induced by LPS in the hippocampus. In addition, APAP increased SOD activity, reduced MDA levels, modulated glycogen synthase kinase 3β (GSK3β) activity and elevated brain-derived neurotrophic factor (BDNF) expression in the hippocampus. Moreover, APAP significantly decreased the Bax/Bcl-2 ratio and neuron apoptosis in the hippocampus of LPS-treated mice.RESULTSMice treated with LPS exhibited impaired performance in the Morris water maze without changing spontaneous locomotor activity, which was ameliorated by treatment with APAP. APAP suppressed the accumulation of pro-inflammatory cytokines and microglial activation induced by LPS in the hippocampus. In addition, APAP increased SOD activity, reduced MDA levels, modulated glycogen synthase kinase 3β (GSK3β) activity and elevated brain-derived neurotrophic factor (BDNF) expression in the hippocampus. Moreover, APAP significantly decreased the Bax/Bcl-2 ratio and neuron apoptosis in the hippocampus of LPS-treated mice.Our results suggest that APAP may possess a neuroprotective effect against LPS-induced cognitive impairment and inflammatory and oxidative stress via mechanisms involving its antioxidant and anti-inflammatory properties, as well as its ability to inhibit the mitochondrial permeability transition (MPT) pore and the subsequent apoptotic pathway.CONCLUSIONSOur results suggest that APAP may possess a neuroprotective effect against LPS-induced cognitive impairment and inflammatory and oxidative stress via mechanisms involving its antioxidant and anti-inflammatory properties, as well as its ability to inhibit the mitochondrial permeability transition (MPT) pore and the subsequent apoptotic pathway. Background Considerable evidence has shown that neuroinflammation and oxidative stress play an important role in the pathophysiology of postoperative cognitive dysfunction (POCD) and other progressive neurodegenerative disorders. Increasing evidence suggests that acetaminophen (APAP) has unappreciated antioxidant and anti-inflammatory properties. However, the impact of APAP on the cognitive sequelae of inflammatory and oxidative stress is unknown. The objective of this study is to explore whether APAP could have neuroprotective effects on lipopolysaccharide (LPS)-induced cognitive impairment in mice. Methods A mouse model of LPS-induced cognitive impairment was established to evaluate the neuroprotective effects of APAP against LPS-induced cognitive impairment. Adult C57BL/6 mice were treated with APAP half an hour prior to intracerebroventricular microinjection of LPS and every day thereafter, until the end of the study period. The Morris water maze was used to assess cognitive function from postinjection days 1 to 3. Animal behavioural tests as well as pathological and biochemical assays were performed to evaluate LPS-induced hippocampal damage and the neuroprotective effect of APAP. Results Mice treated with LPS exhibited impaired performance in the Morris water maze without changing spontaneous locomotor activity, which was ameliorated by treatment with APAP. APAP suppressed the accumulation of pro-inflammatory cytokines and microglial activation induced by LPS in the hippocampus. In addition, APAP increased SOD activity, reduced MDA levels, modulated glycogen synthase kinase 3β (GSK3β) activity and elevated brain-derived neurotrophic factor (BDNF) expression in the hippocampus. Moreover, APAP significantly decreased the Bax/Bcl-2 ratio and neuron apoptosis in the hippocampus of LPS-treated mice. Conclusions Our results suggest that APAP may possess a neuroprotective effect against LPS-induced cognitive impairment and inflammatory and oxidative stress via mechanisms involving its antioxidant and anti-inflammatory properties, as well as its ability to inhibit the mitochondrial permeability transition (MPT) pore and the subsequent apoptotic pathway. Considerable evidence has shown that neuroinflammation and oxidative stress play an important role in the pathophysiology of postoperative cognitive dysfunction (POCD) and other progressive neurodegenerative disorders. Increasing evidence suggests that acetaminophen (APAP) has unappreciated antioxidant and anti-inflammatory properties. However, the impact of APAP on the cognitive sequelae of inflammatory and oxidative stress is unknown. The objective of this study is to explore whether APAP could have neuroprotective effects on lipopolysaccharide (LPS)-induced cognitive impairment in mice. A mouse model of LPS-induced cognitive impairment was established to evaluate the neuroprotective effects of APAP against LPS-induced cognitive impairment. Adult C57BL/6 mice were treated with APAP half an hour prior to intracerebroventricular microinjection of LPS and every day thereafter, until the end of the study period. The Morris water maze was used to assess cognitive function from postinjection days 1 to 3. Animal behavioural tests as well as pathological and biochemical assays were performed to evaluate LPS-induced hippocampal damage and the neuroprotective effect of APAP. Mice treated with LPS exhibited impaired performance in the Morris water maze without changing spontaneous locomotor activity, which was ameliorated by treatment with APAP. APAP suppressed the accumulation of pro-inflammatory cytokines and microglial activation induced by LPS in the hippocampus. In addition, APAP increased SOD activity, reduced MDA levels, modulated glycogen synthase kinase 3β (GSK3β) activity and elevated brain-derived neurotrophic factor (BDNF) expression in the hippocampus. Moreover, APAP significantly decreased the Bax/Bcl-2 ratio and neuron apoptosis in the hippocampus of LPS-treated mice. Our results suggest that APAP may possess a neuroprotective effect against LPS-induced cognitive impairment and inflammatory and oxidative stress via mechanisms involving its antioxidant and anti-inflammatory properties, as well as its ability to inhibit the mitochondrial permeability transition (MPT) pore and the subsequent apoptotic pathway.
ArticleNumber	17
Audience	Academic
Author	Zhang, Yong-Yi Wang, Wei Zhang, Xiao-Ying Cao, Jiang-Bei Zhang, You-Zhi Zhao, Wei-Xing Mi, Wei-Dong Wang, Dong-Xin Yu, Jun Zhang, Jun-Han
Author_xml	– sequence: 1 givenname: Wei-Xing surname: Zhao fullname: Zhao, Wei-Xing organization: Anesthesia and Operation Center, Chinese PLA General Hospital – sequence: 2 givenname: Jun-Han surname: Zhang fullname: Zhang, Jun-Han organization: The Second Affiliated Hospital of Xiangya School of Medicine, Central South University – sequence: 3 givenname: Jiang-Bei surname: Cao fullname: Cao, Jiang-Bei organization: Anesthesia and Operation Center, Chinese PLA General Hospital – sequence: 4 givenname: Wei surname: Wang fullname: Wang, Wei organization: Anesthesia and Operation Center, Chinese PLA General Hospital, Department of Anesthesiology, The General Hospital of the PLA Rocket Force – sequence: 5 givenname: Dong-Xin surname: Wang fullname: Wang, Dong-Xin organization: Department of Anesthesiology and Surgical Intensive Care, Peking University First Hospital – sequence: 6 givenname: Xiao-Ying surname: Zhang fullname: Zhang, Xiao-Ying organization: Anesthesia and Operation Center, Chinese PLA General Hospital – sequence: 7 givenname: Jun surname: Yu fullname: Yu, Jun organization: Anesthesia and Operation Center, Chinese PLA General Hospital – sequence: 8 givenname: Yong-Yi surname: Zhang fullname: Zhang, Yong-Yi organization: Anesthesia and Operation Center, Chinese PLA General Hospital – sequence: 9 givenname: You-Zhi surname: Zhang fullname: Zhang, You-Zhi organization: Institute of Pharmacology and Toxicology, Beijing Key laboratory of Neuropsychopharmacology – sequence: 10 givenname: Wei-Dong surname: Mi fullname: Mi, Wei-Dong email: wwdd1962@aliyun.com organization: Anesthesia and Operation Center, Chinese PLA General Hospital
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/28109286$$D View this record in MEDLINE/PubMed
BookMark	eNp9UkuL1TAULjLiPPQHuJGCGzcdk7RJ2o1wGXzBgBtdhzQ9bc_QJjVJh7n_3pQ7jncGlSxOSL7HeZ1nJ9ZZyLLXlFxSWov3gbJGVgWhoiCypoV4lp1RWbGCkaY6ObqfZuch3BBSMi7Yi-yU1ZQ0rBZnGewMRD2jdcsINtcxgl11hJBPuLjFTfugjRm1xw4KtN1qoMuNGyxGvIUc50Wjn8HGPI7ercOYaxvR3WGXYq5NQmHcv8ye93oK8Oo-XmQ_Pn38fvWluP72-evV7rowvJSxYC0Qwojp255wwzjwlsuq5lIwKrqmMZTJhnQ1MW0reQ8cRF3VsheiqVomyvIi-3DQXdZ2hs6kvLye1OJx1n6vnEb1-MfiqAZ3qzjjtCx5Enh3L-DdzxVCVDMGA9OkLbg1qNR1ypuSy83r7RPojVu9TeVtKE5YJUT1BzXoCRTa3iVfs4mqXSVrzlPum-3lX1DpdDCjSUPvMb0_Irw5LvShwt-DTQB6ABjvQvDQP0AoUdvyqMPyqLQ8alsetXHkE47BqNM0t17h9F8mOzBDcrED-KNe_JP0C_Y52VQ
CitedBy_id	crossref_primary_10_1007_s11064_023_03962_4 crossref_primary_10_1007_s12035_024_04368_1 crossref_primary_10_1007_s40520_025_03152_y crossref_primary_10_5114_ait_2024_146710 crossref_primary_10_1039_D2BM01968J crossref_primary_10_1186_s12974_021_02204_0 crossref_primary_10_1186_s40001_025_02786_y crossref_primary_10_1016_j_neuroscience_2021_11_025 crossref_primary_10_1177_09603271221133547 crossref_primary_10_1186_s12974_023_02958_9 crossref_primary_10_1007_s11011_019_00439_8 crossref_primary_10_3390_biom14040437 crossref_primary_10_1016_j_neuropharm_2021_108935 crossref_primary_10_1007_s10787_023_01324_8 crossref_primary_10_1186_s12868_019_0520_x crossref_primary_10_1007_s12035_021_02717_y crossref_primary_10_1007_s11011_019_00532_y crossref_primary_10_1093_ijnp_pyaa078 crossref_primary_10_3389_fphar_2022_803903 crossref_primary_10_3390_biomedicines12051107 crossref_primary_10_3389_fncel_2018_00396 crossref_primary_10_1016_j_intimp_2018_10_020 crossref_primary_10_1590_s2175_97902022e21530 crossref_primary_10_1186_s12974_019_1627_9 crossref_primary_10_1016_j_neuroscience_2018_12_008 crossref_primary_10_1186_s12974_022_02656_y crossref_primary_10_1016_j_pnpbp_2018_08_016 crossref_primary_10_1016_j_neulet_2019_134372 crossref_primary_10_1016_j_bbi_2020_09_034 crossref_primary_10_1186_s12871_019_0927_z crossref_primary_10_1007_s12031_022_02020_y crossref_primary_10_1016_j_ijbiomac_2023_123797 crossref_primary_10_1097_MD_0000000000032991 crossref_primary_10_2147_NDT_S297365 crossref_primary_10_3389_fnut_2024_1414696 crossref_primary_10_1007_s00401_019_01973_6 crossref_primary_10_15857_ksep_2021_30_2_249 crossref_primary_10_1016_j_bja_2020_06_063 crossref_primary_10_1016_j_brainresbull_2022_01_005 crossref_primary_10_1016_j_exger_2023_112320 crossref_primary_10_3390_antiox12030714 crossref_primary_10_1002_brb3_70121 crossref_primary_10_1186_s12974_020_01905_2 crossref_primary_10_1177_0300060519860026 crossref_primary_10_1007_s12035_020_01982_7 crossref_primary_10_1016_j_neulet_2019_134309 crossref_primary_10_1073_pnas_1916318116 crossref_primary_10_3389_fphar_2022_875349 crossref_primary_10_3390_ijms24054838 crossref_primary_10_3389_fphar_2025_1588978 crossref_primary_10_1016_j_trci_2018_04_004 crossref_primary_10_1016_j_ejphar_2025_177409 crossref_primary_10_1007_s13205_024_04176_3 crossref_primary_10_1002_jbio_202400468 crossref_primary_10_1111_cns_13053 crossref_primary_10_1177_07482337211058671 crossref_primary_10_1007_s10787_018_00559_0 crossref_primary_10_3390_membranes12030317 crossref_primary_10_1016_j_intimp_2021_107431 crossref_primary_10_1016_j_bbi_2021_06_014 crossref_primary_10_1155_sci5_5559483 crossref_primary_10_3390_nu14214599 crossref_primary_10_1016_j_brainresbull_2025_111234 crossref_primary_10_4103_jcrt_JCRT_673_17 crossref_primary_10_1080_01616412_2020_1866353 crossref_primary_10_1016_j_bbi_2021_08_230 crossref_primary_10_2147_JIR_S304461 crossref_primary_10_3389_fimmu_2022_836494 crossref_primary_10_3390_molecules24173052 crossref_primary_10_1016_j_ejphar_2023_175929 crossref_primary_10_1016_j_brainres_2025_149790 crossref_primary_10_1016_j_jchemneu_2021_102008 crossref_primary_10_1007_s00359_022_01557_y crossref_primary_10_3390_scipharm91010011 crossref_primary_10_1016_j_bbi_2024_12_019 crossref_primary_10_1186_s12974_018_1141_5 crossref_primary_10_1016_j_phymed_2022_154538 crossref_primary_10_1002_ibra_12123 crossref_primary_10_1016_j_ebiom_2018_10_021 crossref_primary_10_1016_j_neuropharm_2025_110501
Cites_doi	10.1111/j.1600-079X.1995.tb00133.x 10.1016/S0197-0186(01)00136-X 10.1186/1742-2094-11-36 10.1158/1078-0432.CCR-08-0144 10.1016/j.phrs.2016.02.020 10.1186/s12974-015-0238-3 10.1016/0960-5428(96)00017-4 10.1371/journal.pone.0039656 10.1016/j.mvr.2009.02.002 10.1196/annals.1332.007 10.1038/cddiscovery.2015.62 10.1371/journal.pone.0069123 10.1186/1742-2094-9-101 10.1523/JNEUROSCI.21-17-06718.2001 10.1016/j.neures.2011.05.016 10.3233/JAD-2000-2212 10.1002/dev.20546 10.1096/fj.05-3776fje 10.1002/mas.20258 10.1186/1741-7015-11-32 10.1002/glia.22930 10.1196/annals.1403.002 10.1042/bj3590001 10.1016/j.lfs.2005.10.002 10.1016/S0014-2999(98)00663-3 10.1016/j.brainres.2010.01.013 10.1002/jlb.65.4.409 10.1016/j.tibs.2003.12.004 10.1016/j.bcp.2011.11.009 10.1016/j.physbeh.2014.09.008 10.1097/ALN.0b013e318195b569 10.1186/1742-2094-8-42 10.1016/j.brainresbull.2016.02.001 10.1038/mp.2013.4 10.4103/0970-9185.150530 10.1371/journal.pone.0153708 10.1016/j.neulet.2008.05.003 10.1016/j.neures.2008.07.002 10.1016/j.jss.2012.11.035 10.1159/000443238 10.1177/0269881107076369 10.1016/S0301-0082(01)00011-9 10.1016/j.neuint.2015.07.001 10.1007/s11064-006-9217-5 10.1016/j.bbi.2012.06.004 10.1007/s11064-006-9128-5 10.1038/ni1221 10.1016/S1097-2765(01)00253-2 10.1007/s00232-009-9203-3 10.1016/S0304-3940(00)01294-5 10.1007/s11064-007-9289-x 10.1016/j.expneurol.2007.01.003 10.3164/jcbn.11-73 10.1016/j.peptides.2013.03.029 10.1523/JNEUROSCI.2444-14.2015 10.1038/nprot.2006.116 10.1002/(SICI)1097-4644(19960101)60:1<12::AID-JCB3>3.0.CO;2-6 10.1007/s00109-007-0292-0 10.2165/00002512-200017010-00001 10.1016/j.it.2008.05.002 10.1097/WNR.0b013e32834d38ce 10.1016/S0169-328X(99)00016-9 10.1016/j.biocel.2016.06.015 10.1016/S0140-6736(97)07382-0 10.1523/JNEUROSCI.5620-07.2008 10.1186/1742-2094-6-10 10.1007/s00213-010-1815-x 10.1016/j.brainres.2014.10.019 10.1007/s11011-006-9012-7 10.1016/j.neuropharm.2012.06.027 10.1016/j.neuint.2016.08.005 10.1111/j.1471-4159.2007.04987.x 10.3389/fphar.2011.00072 10.1016/S0165-0173(97)00041-6 10.3109/00207458909002151 10.1016/S0197-0186(03)00170-0 10.1016/j.neulet.2007.09.067 10.1016/j.neuroscience.2016.02.015 10.1186/1742-2094-9-23 10.1016/0092-8674(93)80066-N 10.1016/j.bbi.2005.04.005 10.1016/j.neuroscience.2006.08.017
ContentType	Journal Article
Copyright	The Author(s). 2017 COPYRIGHT 2017 BioMed Central Ltd. Copyright BioMed Central 2017
Copyright_xml	– notice: The Author(s). 2017 – notice: COPYRIGHT 2017 BioMed Central Ltd. – notice: Copyright BioMed Central 2017
DBID	C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7T5 7TK 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM
DOI	10.1186/s12974-016-0781-6
DatabaseName	Springer Nature OA/Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Immunology Abstracts Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) Medical Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles)
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic Publicly Available Content Database MEDLINE
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1742-2094
ExternalDocumentID	PMC5251335 4312146661 A478556695 28109286 10_1186_s12974_016_0781_6
Genre	Research Support, Non-U.S. Gov't Journal Article
GrantInformation_xml	– fundername: National Natural Science Foundation of China grantid: 81471119; 81371204 funderid: http://dx.doi.org/10.13039/501100001809 – fundername: ; grantid: 81471119; 81371204
GroupedDBID	--- 0R~ 29L 2WC 53G 5GY 5VS 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABDBF ABUWG ACGFO ACGFS ACIHN ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHSBF AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EBD EBLON EBS EJD ESX F5P FYUFA GROUPED_DOAJ GX1 H13 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SBL SOJ TR2 TUS UKHRP WOQ WOW XSB ~8M AAYXX AFFHD CITATION -A0 3V. ACRMQ ADINQ ALIPV C24 CGR CUY CVF ECM EIF NPM 7T5 7TK 7XB 8FK AZQEC DWQXO H94 K9. PKEHL PQEST PQUKI PRINS 7X8 5PM
ID	FETCH-LOGICAL-c537t-2be0020cfbf05c25e5b5748576216d99c12790d80cbb75fe5e68487f6694b2633
IEDL.DBID	RSV
ISICitedReferencesCount	94
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000397144400003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1742-2094
IngestDate	Tue Nov 04 02:00:24 EST 2025 Thu Oct 02 10:15:46 EDT 2025 Sat Oct 18 23:53:25 EDT 2025 Tue Nov 11 10:39:04 EST 2025 Tue Nov 04 17:39:29 EST 2025 Wed Feb 19 02:43:40 EST 2025 Sat Nov 29 04:11:10 EST 2025 Tue Nov 18 22:15:23 EST 2025 Sat Sep 06 07:29:58 EDT 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	1
Keywords	Oxidative stress Memory impairment Acetaminophen Antioxidant activity Neuroinflammation Neuroprotective therapy Apoptosis
Language	English
License	Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c537t-2be0020cfbf05c25e5b5748576216d99c12790d80cbb75fe5e68487f6694b2633
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23
OpenAccessLink	https://link.springer.com/10.1186/s12974-016-0781-6
PMID	28109286
PQID	1865024664
PQPubID	55345
ParticipantIDs	pubmedcentral_primary_oai_pubmedcentral_nih_gov_5251335 proquest_miscellaneous_1861593573 proquest_journals_1865024664 gale_infotracmisc_A478556695 gale_infotracacademiconefile_A478556695 pubmed_primary_28109286 crossref_primary_10_1186_s12974_016_0781_6 crossref_citationtrail_10_1186_s12974_016_0781_6 springer_journals_10_1186_s12974_016_0781_6
PublicationCentury	2000
PublicationDate	2017-01-21
PublicationDateYYYYMMDD	2017-01-21
PublicationDate_xml	– month: 01 year: 2017 text: 2017-01-21 day: 21
PublicationDecade	2010
PublicationPlace	London
PublicationPlace_xml	– name: London – name: England
PublicationTitle	Journal of neuroinflammation
PublicationTitleAbbrev	J Neuroinflammation
PublicationTitleAlternate	J Neuroinflammation
PublicationYear	2017
Publisher	BioMed Central BioMed Central Ltd Springer Nature B.V
Publisher_xml	– name: BioMed Central – name: BioMed Central Ltd – name: Springer Nature B.V
References	F Ullah (781_CR12) 2015; 90 HM Gao (781_CR5) 2008; 29 S Schnydrig (781_CR17) 2007; 429 XY Zhang (781_CR19) 2015; 12 S Peng (781_CR8) 2015; 35 J Raber (781_CR40) 1998; 26 TF Zhou (781_CR77) 2013; 183 A Semmler (781_CR18) 2007; 204 F Pinheiro da Silva (781_CR51) 2013; 44 J Zielasek (781_CR42) 1996; 6 R Scott Bitner (781_CR75) 2012; 83 S Rosi (781_CR41) 2006; 142 ER Blough (781_CR22) 2011; 2 PL McGeer (781_CR38) 2004; 1035 V Pitchaimani (781_CR29) 2012; 50 D Casper (781_CR49) 2000; 289 H Maharaj (781_CR24) 2006; 21 MS Khan (781_CR60) 2016; 100 P Wang (781_CR10) 2016; 11 DM Norden (781_CR34) 2016; 64 D Tripathy (781_CR26) 2009; 77 CW Wu (781_CR74) 2007; 103 I Ozmen (781_CR62) 2007; 32 C Landolfi (781_CR58) 1998; 360 IB Hovens (781_CR2) 2012; 26 TT Rohn (781_CR84) 2008; 28 G Leal (781_CR71) 2015; 1621 H Zhang (781_CR82) 2008; 62 R Brandeis (781_CR52) 1989; 48 H Maharaj (781_CR70) 2006; 78 NB Ghate (781_CR78) 2016; 2 L Hritcu (781_CR20) 2011; 71 D Tripathy (781_CR25) 2009; 6 K Belarbi (781_CR14) 2012; 9 C Zhang (781_CR37) 2016; 320 A Benraiss (781_CR46) 2001; 21 MH Kang (781_CR81) 2009; 15 SF Xia (781_CR9) 2015; 138 RS Jope (781_CR44) 2004; 29 DM Hockenbery (781_CR79) 1993; 75 RJ Reiter (781_CR36) 1995; 18 Z Dong (781_CR53) 2013; 64 C Infante-Duarte (781_CR6) 2008; 86 S Frame (781_CR43) 2001; 359 PL McGeer (781_CR55) 2000; 17 CJ Locke (781_CR28) 2008; 439 CV Vorhees (781_CR31) 2006; 1 SD Skaper (781_CR7) 2007; 1122 P Bossu (781_CR15) 2012; 9 L Ren (781_CR39) 1999; 65 MA Lawson (781_CR35) 2013; 10 MS Hernandes (781_CR50) 2014; 11 JR Park (781_CR80) 1996; 60 KG Bath (781_CR45) 2012; 54 CA Grimes (781_CR69) 2001; 65 PJ Maesschalck (781_CR21) 2011; 2 OA Shoair (781_CR1) 2015; 31 M Llorens-Martin (781_CR66) 2013; 18 Z Guan (781_CR72) 2006; 20 SM Yatin (781_CR59) 2000; 2 I Eren (781_CR63) 2007; 32 PL McGeer (781_CR56) 1999; 65 A Rimessi (781_CR61) 2016; 81 RS Jope (781_CR64) 2007; 32 S Frame (781_CR67) 2001; 7 Y Wang (781_CR47) 2013; 11 L Ma (781_CR73) 2016; 121 JH Banoub (781_CR13) 2010; 29 S Chaviaras (781_CR30) 2010; 210 M Naziroglu (781_CR27) 2009; 231 DT Skelly (781_CR33) 2013; 8 M Martin (781_CR65) 2005; 6 HJ Huang (781_CR16) 2012; 7 SS Baliga (781_CR83) 2010; 1319 DJ Silva da (781_CR54) 2016; 23 M Bisaglia (781_CR57) 2002; 41 J Steinmetz (781_CR4) 2009; 110 Y He (781_CR68) 2013; 8 CI Ghanem (781_CR85) 2016; 109 G Wang (781_CR76) 2011; 22 T Ishida (781_CR48) 2007; 21 JP Godbout (781_CR11) 2005; 19 F Hua (781_CR32) 2011; 8 JT Moller (781_CR3) 1998; 351 DS Maharaj (781_CR23) 2004; 44 25447470 - Physiol Behav. 2015 Jan;138:325-31 25206585 - Neural Regen Res. 2013 Oct 15;8(29):2744-53 11563964 - Biochem J. 2001 Oct 1;359(Pt 1):1-16 9651548 - Brain Res Brain Res Rev. 1998 May;26(2-3):320-6 8876774 - Adv Neuroimmunol. 1996;6(2):191-22 22642744 - J Neuroinflammation. 2012 May 29;9:101 26886382 - Neuroimmunomodulation. 2016;23 (1):58-66 18599350 - Trends Immunol. 2008 Aug;29(8):357-65 15919760 - FASEB J. 2005 Aug;19(10):1329-31 21663772 - Neurosci Res. 2011 Sep;71(1):35-43 22844396 - PLoS One. 2012;7(7):e39656 15681803 - Ann N Y Acad Sci. 2004 Dec;1035:104-16 22277195 - J Neuroinflammation. 2012 Jan 25;9:23 25644393 - J Neuroinflammation. 2015 Feb 03;12 :20 19225398 - Anesthesiology. 2009 Mar;110(3):548-55 7503812 - Cell. 1993 Oct 22;75(2):241-51 9845273 - Eur J Pharmacol. 1998 Oct 30;360(1):55-64 11517261 - J Neurosci. 2001 Sep 1;21(17):6718-31 22087105 - Front Pharmacol. 2011 Nov 09;2:72 15922558 - Brain Behav Immun. 2006 Jan;20(1):64-71 22027512 - Neuroreport. 2011 Dec 21;22(18):959-64 17306796 - Exp Neurol. 2007 Apr;204(2):733-40 19838617 - J Membr Biol. 2009 Oct;231(2-3):57-64 21823441 - J Pharm Belg. 2011 Jun;(2):44-5 27116382 - PLoS One. 2016 Apr 26;11(4):e0153708 10961664 - Neurosci Lett. 2000 Aug 11;289(3):201-4 17151918 - Neurochem Res. 2007 Jan;32(1):19-25 8825410 - J Cell Biochem. 1996 Jan;60(1):12-7 23399915 - Mol Psychiatry. 2013 Apr;18(4):451-60 21549006 - J Neuroinflammation. 2011 May 08;8:42 23394076 - BMC Med. 2013 Feb 08;11:32 26851069 - Brain Res Bull. 2016 Mar;121:192-200 18354008 - J Neurosci. 2008 Mar 19;28(12):3051-9 18077562 - Ann N Y Acad Sci. 2007 Dec;1122:23-34 19291322 - J Neuroinflammation. 2009 Mar 16;6:10 10933512 - Drugs Aging. 2000 Jul;17(1):1-11 19265712 - Microvasc Res. 2009 May;77(3):289-96 20589944 - Mass Spectrom Rev. 2010 Jul-Aug;29(4):606-50 22119240 - Biochem Pharmacol. 2012 Mar 15;83(6):705-14 27522965 - Neurochem Int. 2016 Nov;100:1-10 2684886 - Int J Neurosci. 1989 Sep;48(1-2):29-69 15102436 - Trends Biochem Sci. 2004 Feb;29(2):95-102 17976910 - Neurosci Lett. 2007 Dec 11;429(1):69-73 26470014 - Glia. 2016 Feb;64(2):300-16 16989956 - Neuroscience. 2006 Nov 3;142(4):1303-15 26873000 - Neuroscience. 2016 Apr 21;320:210-20 10204568 - J Leukoc Biol. 1999 Apr;65(4):409-15 11918971 - Neurochem Int. 2002 Jul;41(1):43-54 26209154 - Neurochem Int. 2015 Nov;90:114-24 14643753 - Neurochem Int. 2004 Apr;44(5):355-60 24571599 - J Neuroinflammation. 2014 Feb 27;11:36 16007092 - Nat Immunol. 2005 Aug;6(8):777-84 25609639 - J Neurosci. 2015 Jan 21;35(3):1250-9 23634700 - J Neuroinflammation. 2013 May 01;10:54 27551490 - Cell Death Discov. 2016 Jan 18;2:15062 25788770 - J Anaesthesiol Clin Pharmacol. 2015 Jan-Mar;31(1):30-6 22728316 - Brain Behav Immun. 2012 Oct;26(7):1169-79 23236988 - J Surg Res. 2013 Jul;183(1):304-12 27373679 - Int J Biochem Cell Biol. 2016 Dec;81(Pt B):281-293 23840908 - PLoS One. 2013 Jul 01;8(7):e69123 19228717 - Clin Cancer Res. 2009 Feb 15;15(4):1126-32 9525362 - Lancet. 1998 Mar 21;351(9106):857-61 23583479 - Peptides. 2013 Jun;44:135-8 17606472 - J Psychopharmacol. 2007 Sep;21(7):757-67 10064890 - Brain Res Mol Brain Res. 1999 Mar 5;65(2):198-205 18514411 - Neurosci Lett. 2008 Jul 11;439(2):129-33 26921661 - Pharmacol Res. 2016 Jul;109:119-31 12214102 - J Alzheimers Dis. 2000 Jun;2(2):123-131 11430833 - Mol Cell. 2001 Jun;7(6):1321-7 16944320 - Neurochem Res. 2007 Apr-May;32(4-5):577-95 17401662 - Neurochem Res. 2007 Jul;32(7):1188-95 16855872 - Metab Brain Dis. 2006 Sep;21(2-3):189-99 17953674 - J Neurochem. 2007 Dec;103(6):2471-81 22732443 - Neuropharmacology. 2013 Jan;64:65-73 16318861 - Life Sci. 2006 Apr 18;78(21):2438-43 20232054 - Psychopharmacology (Berl). 2010 May;210(1):35-43 18723055 - Neurosci Res. 2008 Oct;62(2):140-6 25451089 - Brain Res. 2015 Sep 24;1621:82-101 17406317 - Nat Protoc. 2006;1(2):848-58 21432850 - Dev Psychobiol. 2012 Sep;54(6):578-89 18196212 - J Mol Med (Berl). 2008 Sep;86(9):975-85 7776173 - J Pineal Res. 1995 Jan;18(1):1-11 20079345 - Brain Res. 2010 Mar 10;1319:142-54 11527574 - Prog Neurobiol. 2001 Nov;65(4):391-426 22573928 - J Clin Biochem Nutr. 2012 May;50(3):241-4
References_xml	– volume: 18 start-page: 1 year: 1995 ident: 781_CR36 publication-title: J Pineal Res doi: 10.1111/j.1600-079X.1995.tb00133.x – volume: 41 start-page: 43 year: 2002 ident: 781_CR57 publication-title: Neurochem Int doi: 10.1016/S0197-0186(01)00136-X – volume: 11 start-page: 36 year: 2014 ident: 781_CR50 publication-title: J Neuroinflammation doi: 10.1186/1742-2094-11-36 – volume: 15 start-page: 1126 year: 2009 ident: 781_CR81 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-08-0144 – volume: 109 start-page: 119 year: 2016 ident: 781_CR85 publication-title: Pharmacol Res doi: 10.1016/j.phrs.2016.02.020 – volume: 12 start-page: 20 year: 2015 ident: 781_CR19 publication-title: J Neuroinflammation doi: 10.1186/s12974-015-0238-3 – volume: 6 start-page: 191 year: 1996 ident: 781_CR42 publication-title: Adv Neuroimmunol doi: 10.1016/0960-5428(96)00017-4 – volume: 7 start-page: e39656 year: 2012 ident: 781_CR16 publication-title: PLoS One doi: 10.1371/journal.pone.0039656 – volume: 77 start-page: 289 year: 2009 ident: 781_CR26 publication-title: Microvasc Res doi: 10.1016/j.mvr.2009.02.002 – volume: 1035 start-page: 104 year: 2004 ident: 781_CR38 publication-title: Ann N Y Acad Sci doi: 10.1196/annals.1332.007 – volume: 2 start-page: 15062 year: 2016 ident: 781_CR78 publication-title: Cell Death Discov doi: 10.1038/cddiscovery.2015.62 – volume: 8 start-page: e69123 year: 2013 ident: 781_CR33 publication-title: PLoS One doi: 10.1371/journal.pone.0069123 – volume: 9 start-page: 101 year: 2012 ident: 781_CR15 publication-title: J Neuroinflammation doi: 10.1186/1742-2094-9-101 – volume: 21 start-page: 6718 year: 2001 ident: 781_CR46 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.21-17-06718.2001 – volume: 71 start-page: 35 year: 2011 ident: 781_CR20 publication-title: Neurosci Res doi: 10.1016/j.neures.2011.05.016 – volume: 2 start-page: 123 year: 2000 ident: 781_CR59 publication-title: J Alzheimers Dis doi: 10.3233/JAD-2000-2212 – volume: 10 start-page: 54 year: 2013 ident: 781_CR35 publication-title: J Neuroinflammation – volume: 54 start-page: 578 year: 2012 ident: 781_CR45 publication-title: Dev Psychobiol doi: 10.1002/dev.20546 – volume: 19 start-page: 1329 year: 2005 ident: 781_CR11 publication-title: FASEB J doi: 10.1096/fj.05-3776fje – volume: 29 start-page: 606 year: 2010 ident: 781_CR13 publication-title: Mass Spectrom Rev doi: 10.1002/mas.20258 – volume: 11 start-page: 32 year: 2013 ident: 781_CR47 publication-title: BMC Med doi: 10.1186/1741-7015-11-32 – volume: 64 start-page: 300 year: 2016 ident: 781_CR34 publication-title: Glia doi: 10.1002/glia.22930 – volume: 1122 start-page: 23 year: 2007 ident: 781_CR7 publication-title: Ann N Y Acad Sci doi: 10.1196/annals.1403.002 – volume: 359 start-page: 1 year: 2001 ident: 781_CR43 publication-title: Biochem J doi: 10.1042/bj3590001 – volume: 78 start-page: 2438 year: 2006 ident: 781_CR70 publication-title: Life Sci doi: 10.1016/j.lfs.2005.10.002 – volume: 360 start-page: 55 year: 1998 ident: 781_CR58 publication-title: Eur J Pharmacol doi: 10.1016/S0014-2999(98)00663-3 – volume: 1319 start-page: 142 year: 2010 ident: 781_CR83 publication-title: Brain Res doi: 10.1016/j.brainres.2010.01.013 – volume: 65 start-page: 409 year: 1999 ident: 781_CR56 publication-title: J Leukoc Biol doi: 10.1002/jlb.65.4.409 – volume: 29 start-page: 95 year: 2004 ident: 781_CR44 publication-title: Trends Biochem Sci doi: 10.1016/j.tibs.2003.12.004 – volume: 83 start-page: 705 year: 2012 ident: 781_CR75 publication-title: Biochem Pharmacol doi: 10.1016/j.bcp.2011.11.009 – volume: 138 start-page: 325 year: 2015 ident: 781_CR9 publication-title: Physiol Behav doi: 10.1016/j.physbeh.2014.09.008 – volume: 110 start-page: 548 year: 2009 ident: 781_CR4 publication-title: Anesthesiology doi: 10.1097/ALN.0b013e318195b569 – volume: 8 start-page: 42 year: 2011 ident: 781_CR32 publication-title: J Neuroinflammation doi: 10.1186/1742-2094-8-42 – volume: 121 start-page: 192 year: 2016 ident: 781_CR73 publication-title: Brain Res Bull doi: 10.1016/j.brainresbull.2016.02.001 – volume: 18 start-page: 451 year: 2013 ident: 781_CR66 publication-title: Mol Psychiatry doi: 10.1038/mp.2013.4 – volume: 31 start-page: 30 year: 2015 ident: 781_CR1 publication-title: J Anaesthesiol Clin Pharmacol doi: 10.4103/0970-9185.150530 – volume: 11 start-page: e0153708 year: 2016 ident: 781_CR10 publication-title: PLoS One doi: 10.1371/journal.pone.0153708 – volume: 439 start-page: 129 year: 2008 ident: 781_CR28 publication-title: Neurosci Lett doi: 10.1016/j.neulet.2008.05.003 – volume: 62 start-page: 140 year: 2008 ident: 781_CR82 publication-title: Neurosci Res doi: 10.1016/j.neures.2008.07.002 – volume: 183 start-page: 304 year: 2013 ident: 781_CR77 publication-title: J Surg Res doi: 10.1016/j.jss.2012.11.035 – volume: 23 start-page: 58 year: 2016 ident: 781_CR54 publication-title: Neuroimmunomodulation doi: 10.1159/000443238 – volume: 21 start-page: 757 year: 2007 ident: 781_CR48 publication-title: J Psychopharmacol doi: 10.1177/0269881107076369 – volume: 65 start-page: 391 year: 2001 ident: 781_CR69 publication-title: Prog Neurobiol doi: 10.1016/S0301-0082(01)00011-9 – volume: 90 start-page: 114 year: 2015 ident: 781_CR12 publication-title: Neurochem Int doi: 10.1016/j.neuint.2015.07.001 – volume: 32 start-page: 19 year: 2007 ident: 781_CR62 publication-title: Neurochem Res doi: 10.1007/s11064-006-9217-5 – volume: 26 start-page: 1169 year: 2012 ident: 781_CR2 publication-title: Brain Behav Immun doi: 10.1016/j.bbi.2012.06.004 – volume: 32 start-page: 577 year: 2007 ident: 781_CR64 publication-title: Neurochem Res doi: 10.1007/s11064-006-9128-5 – volume: 6 start-page: 777 year: 2005 ident: 781_CR65 publication-title: Nat Immunol doi: 10.1038/ni1221 – volume: 7 start-page: 1321 year: 2001 ident: 781_CR67 publication-title: Mol Cell doi: 10.1016/S1097-2765(01)00253-2 – volume: 231 start-page: 57 year: 2009 ident: 781_CR27 publication-title: J Membr Biol doi: 10.1007/s00232-009-9203-3 – volume: 289 start-page: 201 year: 2000 ident: 781_CR49 publication-title: Neurosci Lett doi: 10.1016/S0304-3940(00)01294-5 – volume: 32 start-page: 1188 year: 2007 ident: 781_CR63 publication-title: Neurochem Res doi: 10.1007/s11064-007-9289-x – volume: 204 start-page: 733 year: 2007 ident: 781_CR18 publication-title: Exp Neurol doi: 10.1016/j.expneurol.2007.01.003 – volume: 50 start-page: 241 year: 2012 ident: 781_CR29 publication-title: J Clin Biochem Nutr doi: 10.3164/jcbn.11-73 – volume: 44 start-page: 135 year: 2013 ident: 781_CR51 publication-title: Peptides doi: 10.1016/j.peptides.2013.03.029 – volume: 35 start-page: 1250 year: 2015 ident: 781_CR8 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.2444-14.2015 – volume: 1 start-page: 848 year: 2006 ident: 781_CR31 publication-title: Nat Protoc doi: 10.1038/nprot.2006.116 – volume: 60 start-page: 12 year: 1996 ident: 781_CR80 publication-title: J Cell Biochem doi: 10.1002/(SICI)1097-4644(19960101)60:1<12::AID-JCB3>3.0.CO;2-6 – volume: 86 start-page: 975 year: 2008 ident: 781_CR6 publication-title: J Mol Med (Berl) doi: 10.1007/s00109-007-0292-0 – volume: 17 start-page: 1 year: 2000 ident: 781_CR55 publication-title: Drugs Aging doi: 10.2165/00002512-200017010-00001 – volume: 29 start-page: 357 year: 2008 ident: 781_CR5 publication-title: Trends Immunol doi: 10.1016/j.it.2008.05.002 – volume: 22 start-page: 959 year: 2011 ident: 781_CR76 publication-title: Neuroreport doi: 10.1097/WNR.0b013e32834d38ce – volume: 65 start-page: 198 year: 1999 ident: 781_CR39 publication-title: Brain Res Mol Brain Res doi: 10.1016/S0169-328X(99)00016-9 – volume: 81 start-page: 281 year: 2016 ident: 781_CR61 publication-title: Int J Biochem Cell Biol. doi: 10.1016/j.biocel.2016.06.015 – volume: 351 start-page: 857 year: 1998 ident: 781_CR3 publication-title: Lancet doi: 10.1016/S0140-6736(97)07382-0 – volume: 28 start-page: 3051 year: 2008 ident: 781_CR84 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.5620-07.2008 – volume: 6 start-page: 10 year: 2009 ident: 781_CR25 publication-title: J Neuroinflammation doi: 10.1186/1742-2094-6-10 – volume: 210 start-page: 35 year: 2010 ident: 781_CR30 publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-010-1815-x – volume: 1621 start-page: 82 year: 2015 ident: 781_CR71 publication-title: Brain Res doi: 10.1016/j.brainres.2014.10.019 – volume: 21 start-page: 189 year: 2006 ident: 781_CR24 publication-title: Metab Brain Dis doi: 10.1007/s11011-006-9012-7 – volume: 64 start-page: 65 year: 2013 ident: 781_CR53 publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2012.06.027 – volume: 100 start-page: 1 year: 2016 ident: 781_CR60 publication-title: Neurochem Int. doi: 10.1016/j.neuint.2016.08.005 – volume: 103 start-page: 2471 year: 2007 ident: 781_CR74 publication-title: J Neurochem doi: 10.1111/j.1471-4159.2007.04987.x – volume: 2 start-page: 72 year: 2011 ident: 781_CR22 publication-title: Front Pharmacol doi: 10.3389/fphar.2011.00072 – volume: 26 start-page: 320 year: 1998 ident: 781_CR40 publication-title: Brain Res Brain Res Rev doi: 10.1016/S0165-0173(97)00041-6 – volume: 48 start-page: 29 year: 1989 ident: 781_CR52 publication-title: Int J Neurosci doi: 10.3109/00207458909002151 – volume: 44 start-page: 355 year: 2004 ident: 781_CR23 publication-title: Neurochem Int doi: 10.1016/S0197-0186(03)00170-0 – volume: 2 start-page: 44 year: 2011 ident: 781_CR21 publication-title: J Pharm Belg. – volume: 429 start-page: 69 year: 2007 ident: 781_CR17 publication-title: Neurosci Lett doi: 10.1016/j.neulet.2007.09.067 – volume: 320 start-page: 210 year: 2016 ident: 781_CR37 publication-title: Neuroscience doi: 10.1016/j.neuroscience.2016.02.015 – volume: 9 start-page: 23 year: 2012 ident: 781_CR14 publication-title: J Neuroinflammation doi: 10.1186/1742-2094-9-23 – volume: 75 start-page: 241 year: 1993 ident: 781_CR79 publication-title: Cell doi: 10.1016/0092-8674(93)80066-N – volume: 20 start-page: 64 year: 2006 ident: 781_CR72 publication-title: Brain Behav Immun doi: 10.1016/j.bbi.2005.04.005 – volume: 142 start-page: 1303 year: 2006 ident: 781_CR41 publication-title: Neuroscience doi: 10.1016/j.neuroscience.2006.08.017 – volume: 8 start-page: 2744 year: 2013 ident: 781_CR68 publication-title: Neural Regen Res – reference: 21823441 - J Pharm Belg. 2011 Jun;(2):44-5 – reference: 23583479 - Peptides. 2013 Jun;44:135-8 – reference: 16318861 - Life Sci. 2006 Apr 18;78(21):2438-43 – reference: 12214102 - J Alzheimers Dis. 2000 Jun;2(2):123-131 – reference: 15102436 - Trends Biochem Sci. 2004 Feb;29(2):95-102 – reference: 26921661 - Pharmacol Res. 2016 Jul;109:119-31 – reference: 26851069 - Brain Res Bull. 2016 Mar;121:192-200 – reference: 8825410 - J Cell Biochem. 1996 Jan;60(1):12-7 – reference: 27522965 - Neurochem Int. 2016 Nov;100:1-10 – reference: 10933512 - Drugs Aging. 2000 Jul;17(1):1-11 – reference: 18077562 - Ann N Y Acad Sci. 2007 Dec;1122:23-34 – reference: 17953674 - J Neurochem. 2007 Dec;103(6):2471-81 – reference: 22277195 - J Neuroinflammation. 2012 Jan 25;9:23 – reference: 22027512 - Neuroreport. 2011 Dec 21;22(18):959-64 – reference: 17151918 - Neurochem Res. 2007 Jan;32(1):19-25 – reference: 18723055 - Neurosci Res. 2008 Oct;62(2):140-6 – reference: 23634700 - J Neuroinflammation. 2013 May 01;10:54 – reference: 15681803 - Ann N Y Acad Sci. 2004 Dec;1035:104-16 – reference: 16989956 - Neuroscience. 2006 Nov 3;142(4):1303-15 – reference: 23840908 - PLoS One. 2013 Jul 01;8(7):e69123 – reference: 18599350 - Trends Immunol. 2008 Aug;29(8):357-65 – reference: 27373679 - Int J Biochem Cell Biol. 2016 Dec;81(Pt B):281-293 – reference: 26873000 - Neuroscience. 2016 Apr 21;320:210-20 – reference: 11527574 - Prog Neurobiol. 2001 Nov;65(4):391-426 – reference: 18354008 - J Neurosci. 2008 Mar 19;28(12):3051-9 – reference: 19265712 - Microvasc Res. 2009 May;77(3):289-96 – reference: 25788770 - J Anaesthesiol Clin Pharmacol. 2015 Jan-Mar;31(1):30-6 – reference: 22573928 - J Clin Biochem Nutr. 2012 May;50(3):241-4 – reference: 14643753 - Neurochem Int. 2004 Apr;44(5):355-60 – reference: 11563964 - Biochem J. 2001 Oct 1;359(Pt 1):1-16 – reference: 19225398 - Anesthesiology. 2009 Mar;110(3):548-55 – reference: 15919760 - FASEB J. 2005 Aug;19(10):1329-31 – reference: 17976910 - Neurosci Lett. 2007 Dec 11;429(1):69-73 – reference: 7503812 - Cell. 1993 Oct 22;75(2):241-51 – reference: 22087105 - Front Pharmacol. 2011 Nov 09;2:72 – reference: 20232054 - Psychopharmacology (Berl). 2010 May;210(1):35-43 – reference: 26470014 - Glia. 2016 Feb;64(2):300-16 – reference: 22119240 - Biochem Pharmacol. 2012 Mar 15;83(6):705-14 – reference: 19291322 - J Neuroinflammation. 2009 Mar 16;6:10 – reference: 17606472 - J Psychopharmacol. 2007 Sep;21(7):757-67 – reference: 17406317 - Nat Protoc. 2006;1(2):848-58 – reference: 16944320 - Neurochem Res. 2007 Apr-May;32(4-5):577-95 – reference: 11517261 - J Neurosci. 2001 Sep 1;21(17):6718-31 – reference: 21549006 - J Neuroinflammation. 2011 May 08;8:42 – reference: 22844396 - PLoS One. 2012;7(7):e39656 – reference: 19228717 - Clin Cancer Res. 2009 Feb 15;15(4):1126-32 – reference: 25609639 - J Neurosci. 2015 Jan 21;35(3):1250-9 – reference: 23399915 - Mol Psychiatry. 2013 Apr;18(4):451-60 – reference: 17401662 - Neurochem Res. 2007 Jul;32(7):1188-95 – reference: 18514411 - Neurosci Lett. 2008 Jul 11;439(2):129-33 – reference: 16855872 - Metab Brain Dis. 2006 Sep;21(2-3):189-99 – reference: 25206585 - Neural Regen Res. 2013 Oct 15;8(29):2744-53 – reference: 10064890 - Brain Res Mol Brain Res. 1999 Mar 5;65(2):198-205 – reference: 26209154 - Neurochem Int. 2015 Nov;90:114-24 – reference: 26886382 - Neuroimmunomodulation. 2016;23 (1):58-66 – reference: 17306796 - Exp Neurol. 2007 Apr;204(2):733-40 – reference: 18196212 - J Mol Med (Berl). 2008 Sep;86(9):975-85 – reference: 2684886 - Int J Neurosci. 1989 Sep;48(1-2):29-69 – reference: 25451089 - Brain Res. 2015 Sep 24;1621:82-101 – reference: 21663772 - Neurosci Res. 2011 Sep;71(1):35-43 – reference: 11918971 - Neurochem Int. 2002 Jul;41(1):43-54 – reference: 10961664 - Neurosci Lett. 2000 Aug 11;289(3):201-4 – reference: 25447470 - Physiol Behav. 2015 Jan;138:325-31 – reference: 27551490 - Cell Death Discov. 2016 Jan 18;2:15062 – reference: 9651548 - Brain Res Brain Res Rev. 1998 May;26(2-3):320-6 – reference: 20079345 - Brain Res. 2010 Mar 10;1319:142-54 – reference: 22732443 - Neuropharmacology. 2013 Jan;64:65-73 – reference: 9525362 - Lancet. 1998 Mar 21;351(9106):857-61 – reference: 20589944 - Mass Spectrom Rev. 2010 Jul-Aug;29(4):606-50 – reference: 22728316 - Brain Behav Immun. 2012 Oct;26(7):1169-79 – reference: 21432850 - Dev Psychobiol. 2012 Sep;54(6):578-89 – reference: 11430833 - Mol Cell. 2001 Jun;7(6):1321-7 – reference: 9845273 - Eur J Pharmacol. 1998 Oct 30;360(1):55-64 – reference: 7776173 - J Pineal Res. 1995 Jan;18(1):1-11 – reference: 25644393 - J Neuroinflammation. 2015 Feb 03;12 :20 – reference: 22642744 - J Neuroinflammation. 2012 May 29;9:101 – reference: 16007092 - Nat Immunol. 2005 Aug;6(8):777-84 – reference: 8876774 - Adv Neuroimmunol. 1996;6(2):191-22 – reference: 19838617 - J Membr Biol. 2009 Oct;231(2-3):57-64 – reference: 23394076 - BMC Med. 2013 Feb 08;11:32 – reference: 23236988 - J Surg Res. 2013 Jul;183(1):304-12 – reference: 10204568 - J Leukoc Biol. 1999 Apr;65(4):409-15 – reference: 27116382 - PLoS One. 2016 Apr 26;11(4):e0153708 – reference: 24571599 - J Neuroinflammation. 2014 Feb 27;11:36 – reference: 15922558 - Brain Behav Immun. 2006 Jan;20(1):64-71
SSID	ssj0032562
Score	2.4866772
Snippet	Background Considerable evidence has shown that neuroinflammation and oxidative stress play an important role in the pathophysiology of postoperative cognitive... Considerable evidence has shown that neuroinflammation and oxidative stress play an important role in the pathophysiology of postoperative cognitive... Background Considerable evidence has shown that neuroinflammation and oxidative stress play an important role in the pathophysiology of postoperative cognitive...
SourceID	pubmedcentral proquest gale pubmed crossref springer
SourceType	Open Access Repository Aggregation Database Index Database Enrichment Source Publisher
StartPage	17
SubjectTerms	Acetaminophen Acetaminophen - pharmacology Animals Antioxidants Antioxidants - pharmacology Biomedical and Life Sciences Biomedicine Cognition disorders Cognitive Dysfunction - chemically induced Dosage and administration Drug therapy Hippocampus - drug effects Immunology Lipopolysaccharides Lipopolysaccharides - toxicity Male Maze Learning - drug effects Mice Mice, Inbred C57BL Motor Activity - drug effects Neurobiology Neurology Neuroprotective Agents - pharmacology Neurosciences
SummonAdditionalLinks	– databaseName: ProQuest Central dbid: BENPR link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3Ni9QwFA86K7IXv12rq0QQBCVskzZNepJRdvHisIjC3krzhYW1M05nRP973-ukdTvgXjz1kKS89n0nL79HyCunanBCNjBlgA15zTNWmzwwr0KteCiyTJi-2YRaLPTFRXkeN9y6WFY52MTeULulxT3yE64hlhAIhv5u9YNh1yg8XY0tNG6SA0Qqy2fk4P3p4vzzYIszcOginmXCC0468G4Kqy4gi1aas2LijfZt8hWntF8wuXdq2jujs7v_-xn3yJ0YhtL5Tm7ukxu-fUBuf4oH7Q-Jn1u_qb83LcIOtBRBONsthqX0sllhX4XfXW3xxlbjPIO0HgTE0bEUieLdy2aNG480NgKiNZZV_mocPClepsCeFY_I17PTLx8-stiRgVmZqQ0TxmN8aYMJqbRCemmkyjXkLIIXriwtF6pMnU6tMUoGL32hISMKRVHmRgDjH5NZu2z9E0JB92WQwikHAYLIcgNmuXRa-mAgQgk8IenAmcpGuHLsmnFZ9WmLLqodMyssUUNmVkVC3oxLVjusjusmv0Z2V6jH8F5bx-sIQB0iYlXzXGkJsW4pE3I8mQn6Z6fDA6erqP9d9ZfNCXk5DuNKrGlr_XLbz4FYMpMqS8jRTr5GsoXmaSk0UKkmkjdOQFTw6UjbfOvRwaXAlj1A1ttBRq-Q9a-_8fT6j3hGDgWGMylngh-T2Wa99c_JLftz03TrF1Hp_gB7gDY5 priority: 102 providerName: ProQuest
Title	Acetaminophen attenuates lipopolysaccharide-induced cognitive impairment through antioxidant activity
URI	https://link.springer.com/article/10.1186/s12974-016-0781-6 https://www.ncbi.nlm.nih.gov/pubmed/28109286 https://www.proquest.com/docview/1865024664 https://www.proquest.com/docview/1861593573 https://pubmed.ncbi.nlm.nih.gov/PMC5251335
Volume	14
WOSCitedRecordID	wos000397144400003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVADU databaseName: Open Access: BioMedCentral Open Access Titles customDbUrl: eissn: 1742-2094 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0032562 issn: 1742-2094 databaseCode: RBZ dateStart: 20040101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1742-2094 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0032562 issn: 1742-2094 databaseCode: DOA dateStart: 20040101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1742-2094 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0032562 issn: 1742-2094 databaseCode: M~E dateStart: 20040101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1742-2094 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0032562 issn: 1742-2094 databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1742-2094 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0032562 issn: 1742-2094 databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1742-2094 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0032562 issn: 1742-2094 databaseCode: PIMPY dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLINK Contemporary 1997-Present customDbUrl: eissn: 1742-2094 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0032562 issn: 1742-2094 databaseCode: RSV dateStart: 20041201 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9RAEB9sK-JL_dZoPSIIghKabLIfebyWFn3ocdQPzqeQ3exioKblcif2v3dmLwnNoYK-3HHs7GXYndn5TXY-AF5XskQjZFwkNW5DViZpVOrMRVa6UiZOpCnTvtmEnM3UYpHPuzzuto92768k_Unt1VqJwxYtk6SICfSApUoisQN7aO0UaeP5xy_98ZuiDWfd9eVvp40M0PYxfMMObcdIbl2Uevtzeu-_OL8P-x3cDKcb-XgAt2zzEO6cdRfqj8BOjV2V3-uGygs0IRXbbNYEP8OL-or6J1y3paHMrLqyEbrvKAhVOIQchZRjWS_pBWPYNfwJSwqf_FlX-B1S0gT1pngMn09PPh2_j7rOC5HhqVxFTFvCkcZpF3PDuOWay0yhb8ISUeW5SZjM40rFRmvJneVWKPR8nBB5phlu8BPYbS4b-wxC1HHuOKtkhUCApZnG4zevFLdOIxJxSQBxvx2F6cqSU3eMi8K7J0oUm-UrKBSNlq8QAbwdplxtanL8jfgN7XFB-or_a8ou7QC5o8pXxTSTiiOmzXkAByNK1DMzHu6lpOj0vC3wkRxRjhBZAK-GYZpJsWuNvVx7GsSMKZdpAE83QjWwzVQS50whl3IkbgMBVf8ejzT1N18FnDNqzYNsveuF7gZbf1qN5_9E_QLuMkIxcRKx5AB2V8u1fQm3zY9V3S4nsCMX0n-qCewdnczm5xP_SgN_zT-czb9OvGL-AkEVMJI
linkProvider	Springer Nature
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEB5VKQIuvKGBAkYCIYGs2muvd31AKAKqRm2iHIpUTsb7EpZaJ-QB9E_xG5lxbFNHorceOPmwa2tsfzPz7e48AF4akaMT0s4XCn9DnIeRn6vY-Va4XIQuiSKmqmYTYjyWJyfpZAt-N7kwFFbZ2MTKUJuppj3yvVAil2BUDP397LtPXaPodLVpobGGxaE9_4lLtsW74Uf8v68Y2_90_OHAr7sK-JpHYukzZYkjaadcwDXjlisuYom8m4WJSVMdMpEGRgZaKcGd5TaRyOpdkqSxYgltgKLJ344R7LIH25PhaPKlsf0REghWn52iwHsL9KaCojxw1S5k6Ccd77fpAy44wc0AzY1T2sr57d_-3z7bHbhV02xvsNaLu7Bly3twfVQHEtwHO9B2mZ8VJZVVKD0qMlquiHZ7p8WM-kacL3JNGWmFsX5RGlQA47WhVh7llhZz2lj16kZHXk5ho78Kg1ePkkWoJ8cD-HwlL_kQeuW0tDvgoW3jjjMjDBIgFsUK3U5qJLdOIQNzYR-CBgmZrsuxU1eQ06xalskkW4MnoxA8Ak-W9OFNe8tsXYvkssmvCV4Z2Sl8rs7rdAuUjip-ZYNYSI5cPuV92O3MRPuiu8MNsrLavi2yv7Dqw4t2mO6kmL3STlfVHOTKERdRHx6t8dyKzWQYpEyilKKD9HYCVT3vjpTFt6r6OWfUkgjFetvoxAWx_vU1Hl_-Es_hxsHx6Cg7Go4Pn8BNRtQtCH0W7kJvOV_Zp3BN_1gWi_mzWuE9-HrVyvIHCQqRBw
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Zi9RAEG50lWVfvHWjq0YQBKXZpJM-8jiog6IOCx7sW5O-MLBmh0lG9N9blYvNoIL4lIeuntR0V3V9la6DkKdOlmCEbKDSwDbkZZrR0uSBehlKmQaRZcx0zSbkaqVOT4uToc9pM0a7j1eSfU4DVmmq2-O1C72KK3HcgJWSGD0B3rBUKRWXyZUcewahu_7xy3gUZ2DP2XCV-dtpM2O0eyRfsEm78ZI7l6adLVpe_-9_cYNcG2BovOjl5ia55OtbZP_DcNF-m_iF9W35raqx7EAdYxHOeouwND6r1thX4WdTWszYqpyn4NaDgLh4CkWKMfey2uCHx3hoBBSXGFb5o3LwjDGZAntW3CGfl68_vXxDh44M1PJMtpQZj_jSBhMSbhn33HCZK_BZWCpcUdiUySJxKrHGSB4890KBRxSEKHLDYOPvkr36vPaHJAbd54EzJx0ABJblBo7lwinugwGEEtKIJOPWaDuUK8euGWe6c1uU0P3yaQxRw-XTIiLPpynrvlbH34if4X5r1GP4XVsO6QjAHVbE0otcKg5Yt-AROZpRgv7Z-fAoMXrQ_0bDKzmgHyHyiDyZhnEmxrTV_nzb0QCWzLjMInKvF7CJbabSpGAKuJQz0ZsIsCr4fKSuvnbVwTnDlj3A1otRAC-w9afVuP9P1I_J_smrpX7_dvXuATlgCHSSlLL0iOy1m61_SK7a723VbB512vgLWHQ2Sg
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Acetaminophen+attenuates+lipopolysaccharide-induced+cognitive+impairment+through+antioxidant+activity&rft.jtitle=Journal+of+neuroinflammation&rft.au=Zhao%2C+Wei-Xing&rft.au=Zhang%2C+Jun-Han&rft.au=Cao%2C+Jiang-Bei&rft.au=Wang%2C+Wei&rft.date=2017-01-21&rft.issn=1742-2094&rft.eissn=1742-2094&rft.volume=14&rft.issue=1&rft_id=info:doi/10.1186%2Fs12974-016-0781-6&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_s12974_016_0781_6
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1742-2094&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1742-2094&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1742-2094&client=summon